BusinessLIGAND PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Ligand Pharmaceuticals Investors of Securities Class Action Lead Plaintiff DeadlineBy Nasdaq OMXDec 14, 2016, 2:30 PM UTC
BusinessLIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to Accounting Restatements, Securities Class Action, and Lead Plaintiff DeadlineBy Nasdaq OMXNov 23, 2016, 2:30 PM UTC
